Cuvrior (Trientine Tetrahydrochloride) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cuvrior. Always confirm against the full prescribing information.
100 interactions
Amikacin
Triethylenetetramine may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Calcium
Calcium can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Calcium acetate
Calcium acetate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Calcium chloride
Calcium chloride can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Calcium citrate
Calcium citrate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Calcium glucoheptonate
Calcium glucoheptonate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Calcium gluconate
Calcium gluconate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Calcium lactate
Calcium lactate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Calcium Phosphate
Calcium Phosphate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Calcium polycarbophil
Calcium polycarbophil can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Capreomycin
Triethylenetetramine may decrease the excretion rate of Capreomycin which could result in a higher serum level.
Cuvrior (Trientine Tetrahydrochloride) has 550 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Cuvrior (Trientine Tetrahydrochloride) has 0 major, 72 moderate, and 478 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cuvrior. Always confirm against the full prescribing information.